Sirton Pharmaceuticals

Villa Guardia, Italy Founded: 1944 • Age: 82 yrs Acquired By 3SBio
Injectable pharmaceutical products are manufactured under contract.

About Sirton Pharmaceuticals

Sirton Pharmaceuticals is a Healthcare company based in Villa Guardia (Italy) founded in 1944, and was acquired by 3SBio in January 2015. Injectable pharmaceutical products are manufactured under contract. Sirton Pharmaceuticals offers products and services including Injectable Forms and Development Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Sirton Pharmaceuticals SpA.

Company details

Sirton Pharmaceuticals is a pharmaceutical contract manufacturer engaged in the manufacturing of injectable products. They have capabilities for the manufacturing of prefilled syringes, liquid vials, freeze-dried vials, ampoules and also offer pharmaceutical development, stability studies, and clinical batches. They have capabilities for analytical testing which include chemical, biological and microbiological testing. They have capabilities to manufacture asepticterminally sterilized and biological products. The company was acquired by 3SBio Group, a Chinese biotech company in December 2014.

  • Headquarters Villa Guardia, Italy
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website sirton.it
  • Social LinkedIn
  • Acquired by 3SBio (Jan 2015)
  • Legal Name Sirton Pharmaceuticals Spa
Key Metrics

Products & Services of Sirton Pharmaceuticals

Sirton Pharmaceuticals offers a comprehensive portfolio of products and services, including Injectable Forms and Development Services.

Injectable Forms
Pharmaceutical Products

Aseptic production of syringes, vials, and lyophilized drugs for clients.

Development Services
R&D Services

Support for drug development, stability studies, and clinical batches.

Investors in Sirton Pharmaceuticals

Sirton Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 3SBio.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Fully integrated Chinese Biopharm with a focus on nephrology, oncology, supportive cancer care, inflammation and infectious diseases.
19933sbio.comShenyang, China
Premium access

Investor details for Sirton Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Sirton Pharmaceuticals

2 dated milestones of Sirton Pharmaceuticals across 71 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sirton Pharmaceuticals is founded.
  2. Exit Acquired by 3SBio.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sirton Pharmaceuticals

Sirton Pharmaceuticals was founded in 1944.

Sirton Pharmaceuticals is headquartered in Villa Guardia, Italy. It is registered at Villa Guardia, Lombardy, Italy.

Sirton Pharmaceuticals is a pharmaceutical contract manufacturer engaged in the manufacturing of injectable products. They have capabilities for the manufacturing of prefilled syringes, liquid vials, freeze-dried vials, ampoules and also offer pharmaceutical development, stability studies, and clinical batches. They have capabilities for analytical testing which include chemical, biological and microbiological testing. They have capabilities to manufacture asepticterminally sterilized and biological products. The company was acquired by 3SBio Group, a Chinese biotech company in December 2014.

Sirton Pharmaceuticals offers Injectable Forms and Development Services.

Sirton Pharmaceuticals has 1 investor. Key investors include 3SBio.

Sirton Pharmaceuticals operates through Sirton Pharmaceuticals Spa.

Yes. Sirton Pharmaceuticals was acquired by 3SBio in January 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available